Treatment options for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections

ZHANG Chi1; 2; LING Baodong1; 2

doi:10.3969/j.issn.1673-6184.2018.02.005

Journal of Microbes and Infections >

2018 , Vol. 13 >Issue 2: 90 - 96

DOI: https://doi.org/10.3969/j.issn.1673-6184.2018.02.005

Review

Treatment options for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections

ZHANG Chi1 ,
2 ,
LING Baodong1 ,
2

Expand

1. Small Molecule Drugs Key Laboratory of Sichuan Province, Institute of Materia Medica, Chengdu Medical College, Chengdu 610500, China; 2. Non-coding RNA and Drug Discovery Laboratory, Chengdu Medical College, Chengdu 610500, China

Received date: 2017-06-21

Online published: 2017-04-25

Fold

Abstract

Acinetobacter baumannii (A. baumannii) is the major pathogen causing nosocomial infectious diseases in the world due to various intrinsic and acquired mechanisms of drug resistance. There are no effective treatments for the infections caused by multidrug-resistant A. baumannii and extensively-resistant A. baumannii. This review lists standard drugs and new options for the treatment.

Key words： Multidrug-resistant Acinetobacter baumannii; Extensively-resistant Acinetobacter baumannii; Anti-infection therapy

Cite this article

ZHANG Chi1 , 2 , LING Baodong1 , 2 . Treatment options for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections[J]. Journal of Microbes and Infections, 2018 , 13(2) : 90 -96 . DOI: 10.3969/j.issn.1673-6184.2018.02.005

Options

Outlines

模态框（Modal）标题

Abstract

Cite this article